poster board numbers lupus 2017 & aca 2017 | melbourne ...lupus2017.org/documents/poster board...
TRANSCRIPT
POSTER BOARD NUMBERS
LUPUS 2017 & ACA 2017 | Melbourne, Australia
Monday, 27 March
* Boards PS01-PS04 are located in the foyer outside Room 203-204. These posters should be on display
throughout the Congress.
Last name First name Poster title Board number
Agarwal Manjari LUPUS NEPHRITIS IN CHILDREN: A 7 YEAR SINGLE CENTRE EXPERIENCE FROM INDIA
063
Anggara Mohamad Yanuar AUTOIMMUNE HEMOLYTIC ANEMIA EVOLVING TO SYSTEMIC LUPUS ERYTHREMATOSUS
064
Aravinthan Adithan ENHANCED IMMUNE CELL ACTIVITY BY KOREAN RED GINSENG IN PORCINE
001
Aravinthan Adithan GASTRIC CANCER CELL MICRO ENVIRONMENT MODULATES THE NK CELL EFFICACY IN RAT SPLENOCYTES
002
Azhar Ahmad CARDIOVASCULAR COMPLICATIONS IN PEDIATRIC-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN SAUDI ARABIAN PATIENTS
065
Barrera-Vargas Ana IS SPLENECTOMY A SAFE AND EFFECTIVE THERAPEUTIC OPTION IN SYSTEMIC LUPUS ERYTHEMATOSUS? A SINGLE-CENTER STUDY
025
Bengtsson Anders A LOW PLASMA CONCENTRATIONS OF APOLIPOPROTEIN M CORRELATE TO DISEASE ACTIVITY AND ENDOTHELIAL DYSFUNCTION IN SLE
078
Campos Lucia OUTCOMES OF 847 CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUSUS PATIENTS IN THREE AGE GROUPS
066
Campos Lucia PANNICULITIS IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTRIC COHORT STUDY
067
Carvalho Jozelio SUBCLINICAL MYOCARDIAL DYSFUNCTION BY TISSUE DOPPLER ECHOCARDIOGRAPHY IN PRIMARY ANTIPHOSPHOLIPID SYNDROME: PRELIMINARY RESULTS
014
Cefle Ayse SINGLE CENTER EXPERIENCE WITH 150 SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
123
Cheung Kwok Fan ANNEXIN II-BINDING IMMUNOGLOBULIN G LEVEL CORRELATES WITH CLINICAL AND RENAL HISTOLOGICAL DISEASE ACTIVITY IN LUPUS NEPHRITIS
124
Cho Chul-Soo INCREASED URINARY HEPARANASE LEVELS ARE ASSOCIATED WITH ACTIVE LUPUS NEPHRITIS
125
Choi Yun Jung INDUCTION OF DIFFERENTIATION OF REGULATORY T CELLS COUPLED TO ENDOPLASMIC RETICULUM STRESS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
003
Choi Chan-Bum OUTCOMES OF MULTI-TARGET THERAPY USING MYCOPHENOLATE MOFETIL AND TACROLIMUS FOR REFRACTORY LUPUS NEPHRITIS
026
Choi Yun Jung SUBCLINICAL DETERIORATION OF LEFT VENTRICULAR DIASTOLIC FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS
126
Choy Hoikei EDA+ FIBRONECTIN IN TUBULO-INTERSTITIAL INJURY IN LUPUS NEPHRITIS
127
Cunanan Iricel ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENTING AS SPONTANEOUS HEPATIC RUPTURE
015
Deng Guo-min ETHANOL PREVENTS DAMAGE OF SKIN, KIDNEY AND JOINT IN LUPUS-PRONE MICE BY REGULATING LIPID RAFTS
027
Deng Guo-min JOINT DEPOSITED IGG INDUCES ARTHRITIS BUT INHIBITS OSTEOCLASTOGENESIS IN SLE THROUGH SYK
128
Deng Guo-min ESTROGEN PROMOTES SLE SERUM IgG-induced SKIN INFLAMMATION VIA THE ESTROGEN MEMBRANE RECEPTOR GPER1
129
Deng Guo-min THE MAJOR ROLES OF MONOCYTES AND THEIR PRODUCT TUMOR NECROSIS FACTOR ALPHA IN THE INDUCTION OF SKIN INFLAMMATION TRIGGERED BY INTRADERMAL LUPUS IgG
130
Deng Guo-min THE ROLE OF IL-1 IN SKIN INFLAMMATION INDUCED BY LUPUS SERUM IgG
131
Dubisnky Diana HPV-RELATED PREMALIGNANT AND MALIGNANT LESIONS IN THE LOWER GENITAL AND ANAL TRACTS OF WOMEN WITH SLE
079
Edar Mary Flor Joy CONTRIBUTORS TO DISEASE FLARES AMONG FILIPINO PATIENTS WITH SLE
084
Eldar-Lissai Adi DISEASE BURDEN AND HEALTHCARE RESOURCE UTILIZATION AMONG CUTANEOUS LUPUS ERYTHEMATOSUS PATIENTS WITH DEPRESSION AND/OR ANXIETY; QUANTIFYING THE UNMET NEED
082
Erceg Mary A PATIENT’S FOUR DECADE JOURNEY TO WELLNESS : A MODEL OF CARE FOR LIVING WELL WITH LUPUS
PS-01*
Falanag Marina THE ITALIAN SLE SURVEY BY WEB: INVESTIGATING PATIENTS’ UNMET NEEDS WITH ONLINE SURVEY TOOLS
PS-02*
Fang Xiang HEPATIC DEPOSITED IgG MEDIATED LIVER DAMAGE THROUGH KUPFFER/NATURAL KILLER CELLS AND THEIR PRODUCTS
132
Fernandes das Neves
Marisa ANTIBODIES TOWARDS ATP-BINDING CASSETTE TRANSPORTER ABCA1: A NEW MECHANISM FOR ATHEROSCLEROSIS IN SLE?
083
Fikry Achmad RHUPUS SYNDROME : A CASE REPORT AND LITERATURE REVIEW 133
Furie Richard BIIB059, A MONOCLONAL ANTIBODY TARGETING BDCA2, DEMONSTRATES EVIDENCE OF PROOF OF BIOLOGICAL ACTIVITY IN SUBJECTS WITH CUTANEOUS LUPUS
028
G Arvind STUDY OF CLINICAL UTILITY OF ANTIBODIES TO PHOSPHATIDYLSERINE/ PROTHROMBIN COMPLEX IN INDIAN PATIENTS
016
G Dharmanand Balebail PROSPECTIVE SINGLE CENTRE STUDY OF EFFECTIVENESS OF UPFRONT RITUXIMAB AND MYCOPHENOLATE WITH MINIMUM STEROID IN SLE
029
Gladman Dafna ACCRUAL OF DISEASE COMORBIDITIES OVER 8 YEARS IN A MULTICENTRE INCEPTION SLE COHORT
100
Gladman Dafna ASSOCIATION BETWEEN CHRONIC ANTIMALARIAL THERAPY AND ELEVATED MYOCARDIAL BIOMARKERS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND NO PRIOR HEART DISEASE: A PRELIMINARY REPORT
101
Gladman Dafna EFFECT OF COMPLETE OR PARTIAL PROTEINURIA RECOVERY COMPARED TO NO RECOVERY AT 2 YEARS AFTER THE DIAGNOSIS OF LUPUS NEPHRITIS ON LONG TERM OUTCOMES
138
Gómez-Puerta Jose A SAFETY OF BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN CLINICAL PRACTICE SETTING
030
Gunawan Hendra NEUTROPHIL-TO-LYMPHOCYTE RATIO AND SYSTEMIC LUPUS ERYTHEMATOSUS: A NEW PARAMETER FOR DISEASE ACTIVITY ASSESSMENT?
085
Gunawan Hendra DYSLIPIDEMIA AND DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUS: AN INDEPENDENT RISK FACTOR
086
Guo Qiang PULMONARY DISORDERS IN LUPUS PATIENT WITH NEPHRITIS 087
Gupta Neetu THE MEMBRANE-CYTOSKELETON LINKER EZRIN AND Src FAMILY KINASE LYN COLLABORATE TO MAINTAIN OPTIMAL B CELL ACTIVATION AND PREVENT THE DEVELOPMENT OF AUTOIMMUNITY
004
Gupta Aman SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID ANTIBODIES IN A CHILD WITH NOONAN SYNDROME
068
Hall Susan Audrey SYMPTOM IMPACT AND UNMET NEED IN SYSTEMIC/CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM A PATIENT-CENTERED STUDY SET IN A SOCIAL MEDIA COMMUNITY
088
Hamijoyo Laniyati ASSOCIATION BETWEEN HYPERTENSION AND PROTEINURIA IN SYSTEMIC LUPUS ERYTHEMATOSUS
089
Hanly John SJOGREN’S SYNDROME AND LOCALIZED NODULAR CUTANEOUS AMYLOIDOSIS: NEW INSIGHTS INTO THE LINK BETWEEN THE TWO
090
Hellmi Rakhma yanti CORRELATION BETWEEN PLASMA LEVELS OF TNF-α AND CAROTID ARTERY INTIMA MEDIA THICKNESS IN SLE
091
Hitchon Carol ACTIVE ARTHRITIS IS ASSOCIATED WITH 14-3-3eta TITRE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
134
Inanc Nevsun EARLY RESULTS OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING PULMONARY ENDARTERECTOMY
092
Ishizaka Sally SELECTIVE AND ORALLY AVAILABLE SMALL MOLECULE INHIBITORS OF TLR7 AND 8 FOR THE TREATMENT OF LUPUS
031
Islam Md. Nazrul CLINICAL EVALUATION OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS FOR SKIN LESIONS-REPORT FROM A DEVELOPING COUNTRY
093
Itomi Yasuo IXAZOMIB, AN ORAL PROTEASOME INHIBITOR, REDUCES ANTIBODY PRODUCTION BY DEPLETING PLASMA CELLS IN A T CELL DEPENDENT ANTIGEN RESPONSE MODEL
005
Itomi Yasuo IXAZOMIB, AN ORAL PROTEASOME INHIBITOR, DEPLETES PLASMA CELLS REDUCING AUTOANTIBODIES AND pDCs in PRE-CLINICAL MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS
032
Jarjour Wael TLR7 AND TLR8 TARGETED Micro-RNAs INHIBIT SIGNALING AND SUPPRESS INFLAMMATION IN A NOVEL HUMAN-MOUSE CHIMERIC MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS
033
Jindal Ankur RITUXIMAB IN THE MANAGEMENT OF ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED CHOREA IN A CHILD WITH LUPUS
017
Jindal Ankur AN UNUSUAL CASE OF PEDIATRIC LUPUS WITH ISOLATED RETINAL INVOLVEMENT
069
Jindal Ankur SKIN PEELING AND IRRITABILITY IN A YOUNG BOY WITH SYSTEMIC LUPUS ERYTHEMATOSUS- IS THERE AN OVERLAP WITH KAWASAKI DISEASE?
070
Jindal Ankur NEUROPSYCHIATRIC LUPUS WITH HEPATITIS IN A CHILD WITH CMV CO-INFECTION: IS CMV A SIMPLE BY-STANDER?
071
Johana Carmona Pérez
Liseth EFFECT OF MICROPARTICLES DERIVED FROM PATIENTS WITH LUPUS ERYTHEMATOSUS SYSTEMIC (SLE) ON MODULATION OF microRNAs 146a and 126, IN A MONOCYTE CELL LINE
053
Johnson Geoff SAFETY, EFFICACY AND TRANSCRIPTIONAL CHANGES FOLLOWING REPEATED ADMINISTRATION OF DAPIROLIZUMAB PEGOL IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A PHASE I STUDY
034
Kalim Handono POTENTIAL NOVEL NATURAL B CELL DEPLETING AND IMMUNOSUPPRESSION AGENT IN LUPUS TREAPMENT USING BRYOPHYLLUM PINNATUM.IN SILICO AND IN PRISTANE INDUCED LUPUS MICE
035
Kalim Handono EFFECT OF CURCUMIN AND VITAMIN D ON DISEASE ACTIVITY, FATIGUE, AND CYTOKINE PROFILE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH DEFICIENCY VITAMIN D
036
Kalim Handono IMMUNE MODULATION EFFECTS OF CURCUMIN IN PRISTANE INDUCED LUPUS MICE
037
Kalim Handono DEVELOPMENT OF THERAPY USING BRYOPHYLLUM PINNATUM TO DECREASE MATURATION AND INCREASE APOPTOTIC B CELLS FROM BALB/C LUPUS MICE: IN SILICO AND IN VITRO STUDY APPROACH
038
Katagiri Takaharu A CASE OF DERMATOMYOSITIS WITH ELEVATED SERUM KL-6 LEVEL ASSOCIATED WITH OVARIAN CANCER
PS-03*
Kato Yuko AUTOANTIBODIES IN SLE WITH PULMONARY HYPERTENSION PROMOTE A MIGRATION OF PULMONARY ARTERY SMOOTH MUSCLE CELLS
094
Khor Chiew Gek ACUTE PANCREATITIS AS AN INITIAL MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS : TWO CASE REPORTS
135
Khosravi-Hafshejani
Touraj PRIOR SUN EXPOSURE AND SKIN-SPECIFIC AUTO-ANTIBODIES ARE ASSOCIATED WITH SKIN DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS
136
Kim Juyang ABSENCE OF HOST CD137 SIGNALING CONVERTS CHRONIC GVHD TOWARD ACUTE GVHD
006
Kim Woo Jin DYSBIOSIS AND GUT BARRIER DYSFUNCTION IN ANTIPHOSPHOLIPID SYNDROME AS REVEALED BY IGA-SEQ PROFILING
018
Kim Ji-Min IMPLICATIONS OF AUTOPHAGY FOR FUNCTINAL CHANGES OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES
022
Kim Hae-Rim N-ACETYL-L-CYSTEINE (NAC) CONTROLS OSTEOCLASTOGENESIS THROUGH REGULATING TH17 DIFFERENTIATION AND RANKL PRODUCTION IN RHEUMATOID ARTHRITIS
054
Kim Kwangnam A CASE OF CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME WAS CONTROLLED WITH RITUXIMAB
072
Koilubaeva Gulazyk THE CLINICAL AND LABORATORY FEATURES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN KYRGYZSTAN
095
Kuo Chang-Fu COMORBIDITIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS PRIOR TO AND FOLLOWING DIAGNOSIS: CASE-CONTROL STUDY
096
Kurniati Nia CALCIUM AND VITAMIN D STATUS IN LUPUS CHILDREN IN JAKARTA, INDONESIA
073
Kurniawan Andree RISK FACTORS ASSOCIATED WITH THE OCCURRENCE OF AUTOIMMUNE HEMOLYTIC ANEMIA IN SYSTEMIC LUPUS ERYTHEMATOSUS
137
Lateef Aisha QUNANTITATIVE AND FUNCTIONAL EVALUATION OF PLASMA MICROPARTICLES IN SYSTEMIC LUPUS ERYTHEMATOSUS
055
Lee Eun-Ju URINARY BIOMARKER RELATED WITH TUBULAR INFLAMMATION IN LUPUS NEPHRITIS
039
Lee Jisoo PREVALENCE AND RISK FACTORS ASSOCIATED WITH NEUTROPENIA IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS
081
Li Ting THE PHARMACOTHERAPEUTIC PATTERN OF LUPUS NEPHRITIS PATIENTS AND ITS EFFECT ON THE HOSPITALIZATION COST IN CHINA
097
Li Tzu-Hao ELDERLY SLE PATIENTS WITH PREVIOUS SKIN HERPES INFECTION AND HIGHER DOSE OF STEROID ENHANCED THE RISK OF SEVERE HERPES SIMPLEX INFECTION: A NATIONWIDE STUDY
098
Lim Ee Xin DELETION OF TACI PROTECTS AGAINST AUTOIMMUNE DISEASE IN LUPUS-PRONE MOUSE MODELS WITH DIFFERENT DISEASE MECHANISMS
040
Lizola Rene THE RELEVANCE OF VASCULAR EVALUATION IN SYSTEMIC LUPUS ERYTHEMATOSUS. RESULTS FROM AN INCEPTION COHORT
099
Ma Chi TERIFLUNOMIDE SODIUM CAN EFFECTIVELY CONTROL PROGRESS OF SPONTANEOUS LUPUS OF MRL/LPR MOUSE
041
Marpaung Blondina RELATIONSHIP BETWEEN INCREASED LEVELS OF ANTI-dsDNA WITH CLINICAL SYMPTOMS IN PATIENTS WITH SLE
139
Matsumoto Mitsuru EXPRESSION OF Ly6C/6G DEFINES A NOVEL AIRE-DEPENDENT SUBSET OF MEDULLARY THYMIC EPITHELIAL CELLS WITH TOLEROGENIC FUNCTION
007
Mazur-Nicorici Lucia ASSESSMENT OF THE RISK OF FLARES IN SYSTEMIC LUPUS ERITHEMATOSUS
102
McMahon Maureen BIOMARKERS OF ATHEROSCLEROSIS IN SLE IMPROVE AFTER TREATMENT WITH MYCOPHENOLATE MOFETIL
103
McMahon Maureen PLASMA MYELOPEROXIDASE IS INVERSELY ASSOCIATED WITH FUTURE ATHEROSCLEROSIS PROGRESSION AND INFLAMMATORY HDL FUNCTION IN SLE
104
Merayo-Chalico Javier EPIDEMIOLOGIC PROFILE OF ERECTILE DYSFUNCTION IN SLE: A MULTI-CENTER STUDY IN LATIN AMERICAN PATIENTS
105
Meroni Marianna SELECTED NAILFOLD CAPILLAROSCOPY PARAMETERS ARE PREDICTIVE OF SLE ONSET IN CONNECTIVE TISSUE DISEASES SUBGROUP
140
Minodora Mazur ASSESSMENT OF THE RISK OF FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS
141
Mizushina Kennosuke ACUTE MYOSITIS AS A FLARE MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS
106
Mohd Noh Malehah SERUM 25-HYDROXYVITAMIN D3 LEVELS AND CLINICAL COURSE OF SYSTEMIC LUPUS ERYTHEMATOSUS : A CROSS SECTIONAL RETROSPECTIVE COHORT STUDY IN A REFERRAL CENTRE
142
Mok Chi-Chiu EFFECT OF THE METABOLIC SYNDROME ON ORGAN DAMAGE AND MORTALITY IN CHINESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS
107
Molina Ramon Miguel CHARACTERISTICS AND RISK FACTORS FOR TUBERCULOSIS INFECTION AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
108
Molina Ramon Miguel PROTEIN-LOSING ENTEROPATHY AND FULMINANT INTESTINAL VASCULITIS IN A FILIPINO LUPUS PATIENT: A CASE REPORT
143
Molina Ramon Miguel GASTROINTESTINAL FLARES AMONG FILIPINO PATIENTS WITH SLE: A CASE SERIES
144
Monaghan Katherine DEPLETION OF PLASMACYTOID DENDRITIC CELLS WITH JNJ-56022473 MINIMISES INDUCTION OF AN INTERFERON GENE SIGNATURE IN RESPONSE TO TLR9 AND SLE IMMUNE COMPLEX STIMULATION
042
Muhammed Hafis PREVALENCE OF NPSLE IN NORTH-INDIAN SLE PATIENTS AND ITS IMPACT ON QUALITY OF LIFE
145
Musdalita Eva MASSIVE PAINLESS ASCITES A RARE FORM OF ONSET OF SYSTEMIC LUPUS ERYTHEMATOSUS : A CASE REPORT
146
Na Luo APOPTOSIS:INITIATION AND PROPAGATION IN THE KINETIC PROCESS OF SYSTEMIC LUPS ERYTHEMATOSUS
056
Nakayamada Shingo THE PATHOGENIC RELEVANCE OF T FOLLICULAR HELPER CELLS-PLASMABLASTS AXIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
008
Nasir Noreen MYCOPHENOLATE MOFETIL FOR INDUCTION OF REMISSION IN LUPUS ENTERITIS
147
Nataraja Champa GILZ REPRESENTS A CHECKPOINT LIMITING CYCLICAL EXACERBATION OF INFLAMMATION IN SLE BY TYPE I INTERFERON
043
Nugraha Ricardo Adrian VITAMIN D DEFICIENCY AS NOVEL RISK FACTOR OF ACCELERATED ATHEROSCLEROSIS CARDIOASCULAR DISEASES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
109
Ogawa Eisuke SYSTEMIC LUPUS ERYTHEMATOSUS PRESENTING AS OCULOMOTOR DISTURBANCE
148
Okada Masato EARLY SEQUENTIAL COMBINATION THERAPY WITH MIZORIBINE AND TACROLIMUS IN SIXTY THREE PATIENTS OF LUPUS NEPHRITIS IN A SINGLE CENTER IN JAPAN
149
Oke Vilija DEFINING SUBSETS IN SLE: THE INTERPLAY AMONG IFN-λ1, IFN-α and Th17 AXIS CYTOKINES
150
Olsen Nancy REPOSITORY CORTICOTROPIN INJECTION EXERTS DIRECT ACUTE EFFECTS ON HUMAN B CELL GENE EXPRESSION DISTINCT FROM THE ACTIONS OF GLUCOCORTICOIDS
009
Paramaiswari Ayu CASE REPORT: ELECTROLYTE ABNORMALITY CAUSED BY SUSPECTED ACQUIRED GITELMAN SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT
111
Park Yong-Wook MUCOSAL-ASSOCIATED INVARIANT T CELL DEFICIENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS IS RELATED TO TO AN INTRINSIC DEFECT IN THE CA2+/CALCINEURIN/NFAT1 SIGNALING PATHWAY.
057
Parodis Ioannis SMOKING AND PRE-EXISTING ORGAN DAMAGE REDUCE THE EFFICACY OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS
044
Parodis Ioannis A MASS CYTOMETRY (CYTOF) APPROACH TO STUDY B CELL ALTERATIONS DURING BAFF BLOCKADE TREATMENT WITH BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS
045
Petri Michelle IMPACT OF DISEASE ACTIVITY ON ORGAN DAMAGE RISK OVER TIME IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) —THE HOPKINS LUPUS COHORT
110
Rangkuti Deske Muhadi MASSIVE PERICARDIAL EFFUSION IN YOUNG FEMALE OF SYSTEMIC LUPUS ERYTHEMATOSUS
114
Rus Horea RESPONSE GENE TO COMPLEMENT-32 PROMOTES PLASMA CELL DIFFERENTIATION AND ENHANCES LUPUS-LIKE CHRONIC GRAFT VERSUS HOST DISEASE
010
Sakata Kei TOLL-LIKE RECEPTOR 7-, BUT NOT TOLL-LIKE RECEPTOR 9-, MEDIATED INTERFERON-Α PRODUCTION FROM PLASMACYTOID DENDRITIC CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
046
Sandal Sapna SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR Κ B LIGAND (S RANK-L) LEVELS IN PEDIATRIC ONSET SLE
074
Santos Vivian REASONS FOR HOSPITALIZATION AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
112
Sawhney Sujata CLINICAL PROFILE AND LONG TERM OUTCOME OF CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS
075
Serrano Morales Rosa Maria ANTIPHOSPHOLIPID SYNDROME LONG TERM FOLLOW UP: REAL LIFE EXPERIENCE OF A SINGLE CENTRE
019
Shimamura Sanae RasGRP4 EXPRESSION IN RHEUMATOID SYNOVIUM PLAYS A CRITICAL ROLE VIA Ras- MAPK PATHWAY
023
Sinha Rajiv RITUXIMAB IN SLE MEMBRABOUS NEPHROPATHY 076
Siripaitoon Boonjing RISK FACTORS FOR BACTEREMIA IN THAI PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
115
Sjöberg AnnaKajsa SYSTEMIC LUPUS ERYTHEMATOSUS AND NEUROMYELITIS OPTICA SPECTRUM DISORDERS
116
Subramani Priyanka A RETROSPECTIVE ANALYSIS ON SYSTEMIC LUPUS ERYTHEMATOSUS IN THE INDIGENOUS AND NON-INDIGENOUS POPULATION IN CENTRAL AUSTRALIA FOCUSSING ON TREATMENT AND OUTCOMES OF LUPUS NEPHRITIS
118
Suh Chang-Hee THE LIVER X RECEPTOR IS HIGHLY UPREGULATED IN MONOCYTE DERIVED MACROPHAGE AND POTENTIATES TLR-DRIVEN CYTOKINE RELEASE ACCORDING TO GENOTYPE OF -1830 T > C POLYMORPHISM
058
Suh Chang-Hee HIERARCHICAL CLUSTER ANALYSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
151
Su-Jin Moon FACTORS INFLUENCING ON HEALTH-RELATED QUALITY OF LIFE IN FEMALE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH FIBROMYALGIA
117
Sun Fangfang TTP SECONDARY TO SLE: RITUXIMAB IMPROVES OVERALL BUT NOT RENAL SURVIVAL
119
Suryajaya Bernard Santoso ANTI-NUCLEAR ANTIBODY PATTERN AND CLINICAL MANIFESTATION PRESENTATION IN SYSTEMIC LUPUS ERYTHEMATOSUS
152
Svenungsson Elisabet ISCHEMIC STROKE IN SYSTEMIC LUPUS ERYTHEMATOSUS, -DISTRIBUTION OF SUBTYPES AND A RISK GENOTYPE IN THE STAT4 GENE
153
Syarief Dian LUPUS EXERCISE AND PERSONAL MEDICATION RECORD ON MOBILE APPLICATION TO HELP IMPROVE THE QUALITY OF LIFE OF PEOPLE WITH LUPUS
PS-04*
Tanaka Yoshiya EFFECTS OF BELIMUMAB ON CORTICOSTEROID USE IN A PIVOTAL PHASE III, RANDOMISED, PLACEBO CONTROLLED STUDY IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN NORTH EAST ASIA
047
Tang Wei TARGETING SAHH AS A POTENTIAL THERAPEUTIC STRATEGY FOR AUTOIMMUNE DISEASES
048
Taylor Kristen EFFECTS OF AN ORAL SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR IN A MOUSE MODEL OF SLE
024
Ugarte Berzal Estefania MATRIX METALLOPROTEINASE-9/MMP-9/GELATINASE B IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
059
Ugarte-Gil Manuel PROTECTIVE EFFECT OF ANTIMALARIALS ON THE RISK OF DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS
113
Vasdev Vivek DEMOGRAPHY, CLINICAL AND IMMUNOGICAL PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS FROM A TERTIARY CARE CENTER IN INDIA
154
Venegas Elaine CORRELATION OF HISTOPATHOLOGY WITH CLINICAL PARAMETERS IN LUPUS NEPHRITIS AMONG FILIPINOS
155
Virachitth Siriphone SOME ANTI-CALDIOLIPIN-BETA2-GPI ANTIBODIES BRING THROMBOPHILIC DIATHESIS BY THE DUAL REACTIVITY TO DNA AND INTERNALIZATION TO LIVE CELLS ACCOMPANYING DNA
020
Wong Josalind A LIFE LIVED WITH LUPUS: AN INTEGRATIVE REVIEW OF THE LITERATURE
060
Wu Chao-Yi ROLE OF TUBULOINTERSTITIAL LESIONS IN PREDICTING RENAL OUTCOME AMONG PEDIATRIC ONSET LUPUS NEPHRITIS – A RETROSPECTIVE COHORT STUDY
077
Yan Qingran IGURATIMOD INHIBITS HUMAN B CELL TERMINAL DIFFERENTIATION IN VITRO AND MAY BENEFIT PATIENTS WITH REFRACTORY LUPUS NEPHRITIS
049
Yang Huang-Yu MICROMANAGING LUPUS NEPHRITIS: MIR17-92 MODULATES REGULATORY T CELL ACTIVITY BY TARGETING FOXP3 CO-REGULATORS
011
Yang Yingyun PAN-DYSAUTONOMIA IN SYSTEMIC LUPUS ERYTHEMATOUS: TWO CASES OF SUCCESSFUL TREATMENT AND A REVIEW OF LITERATURE
120
Yap Desmond Yat-Hin LONG-TERM DATA ON SIROLIMUS TREATMENT IN LUPUS NEPHRITIS PATIENTS
050
Yim Ada Lok Yan DENDRITIC CELLS DISPLAY ABERRANT TOLL-LIKE RECEPTOR 7/9 RESPONSES IN SYSTEMIC LUPUS ERYTHEMATOSUS
061
Yoshinari Hiroko SUCCESSFUL TREATMENT OF REFRACTORY LUPUS NEPHRITIS WITH SECUKINUMAB IN A PATIENT COMPLICATED WITH PSORIASIS VULGARIS.
051
Zamora Leonid ROLE OF SEROLOGY IN DIAGNOSIS OF EARLY SLE AMONG FILIPINOS
156
Zapata Carlos Andres PROCALCITONIN AND EOSINOPENIA AS POTENTIAL BIOMARKERS OF INFECTION IN CRITICALLY ILL PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
121
Zapata Carlos Andres THE ROLE OR NEUTROPHIL-LYMPHOCYTE RATIO (NLR), AND OTHER BIOMARKERS (C - REACTIVE PROTEIN CRP, COUNT OF MONOCITES AND LYMPHOCITES) DIFFERENTIATING LUPIC ACTIVITY (FLARE) FROM INFECTION.
122
Zhao Jiuliang LONG-TERM PROGNOSIS AND PREDICTING FACTORS OF CHINESE PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
021
Zhao Jiuliang THE PIVOTAL ROLE OF INTENSIVE IMMUNOSUPPRESSIVE THERAPY IN THE MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED WITH PULMONARY ARTERIAL HYPERTENSION
157
Zhao Jiuliang LONG-TERM PROGNOSIS AND PREDICTING FACTORS OF CHINESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTI-CENTER COHORT STUDY FROM CSTAR REGISTRY
158
Zhong Wei A HIGHER FREQUENCIES OF T HELPER 22 CELLS IN PATIENTS WITH NEW ONSET ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS
012
Zhou Qiao ALTERED PROPORTION OF TFH17 SUBSETS IN BRONCHOLALVEOLAR LAVAGE FLUID OF PATIENTS WITH INTERSTITIAL LUNG DISEASE CAUSED BY SYSTEMIC LUPUS ERYTHEMATOSUS
013
Zhou Haibo MIR-127-3p AS A NOVEL REGULATOR OF TYPE I INTERFERON SIGNALING PATHWAY IN SLE
062
Zuo Jianping DEVELOPMENT OF ARTEMISININ ANALOG SM934 IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
052
Tuesday, 28 March
Last name First name Poster title Board number
Alzate Maria COFFEE CONSUMPTION AND CLINICAL OUTCOMES IN COLOMBIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
081
Bae Sang Cheol UPDATE ON SLE-HLA ASSOCIATION: CONTRIBUTION OF ALLELE-SPECIFIC EXPRESSION IN ADDITION TO AMINO ACID CHANGES IN HLA ALLELES
015
Bankole Adegbenga A COMPARATIVE ANALYSIS OF GUT MICROBIOTA BETWEEN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND NON-AUTOIMMUNE CONTROLS: A SINGLE CENTER COHORT EXPERIENCE
082
Bankole Adegbenga A COMPARATIVE STUDY OF VITAMIN D LEVELS IN AUTOIMMUNE AND NON-AUTOIMMUNE DISEASE
083
Bankole Adegbenga THE RELATIONSHIP BETWEEN SOCIOECONOMIC FACTORS AND IMMUNOSUPPRESSIVE USE IN SYSTEMIC LUPUS ERYTHEMATOSUS
118
Berthier Celine C PEARL: PATHWAY EXPLORATION AND ANALYSIS IN RENAL DISEASE IN THE ACCELERATING MEDICINE PARTNERSHIP (AMP) LUPUS NETWORK
016
Bo miao Ju THE EXPRESSION OF SIGLEC-10 IS ELEVATED ON B LYMPHOCYTES AND ASSOCIATED WITH DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
017
Brilot Fabienne HUMAN AUTOANTIBODIES FROM CHILDREN WITH MOVEMENT AND PSYCHIATRIC DISORDERS TARGET THE EXTRACELLULAR N-TERMINUS OF DOPAMINE-2 RECEPTOR
018
Budde Petra NOVEL AUTOANTIBODIES AGAINST THE INTERFERON-RESPONSIVE MAJOR VAULT PROTEIN (MVP) IN SYSTEMIC LUPUS ERYTHMATOSUS
019
Bundell Chrisitne ANTINUCLEAR ANTIBODIES IN IU/ML PREDICTS dsDNA AND ENA ANTIBODIES
087
Chan Edward High Titer ANA with Anti-DFS70 ALONE IS NOT TO BE CONSIDERED A VALID CRITERION FOR LUPUS
001
Chan Madelynn SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) OF INTEGRIN-ALPHA-M (ITGAM) ARE ASSOCIATED WITH LUPUS NEPHRITIS (LN) IN AN ASIAN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) COHORT
020
Chen Xiaosan THE COMPARISON BETWEEN CHEMILUMINESCENT IMMUNOASSAY AND LINE IMMUNOASSAY FOR THE DETECTION OF ANTIBODIES SPECIFIC TO SLE DIAGNOSIS: A RANDOMIZED, INDEPENDENT MULTI-CENTER CLINICAL STUDY IN CHINA
088
Chen Yen Fu PERICARDIAL EFFUSION AND CARDIAC TAMPONADE IN SYSTEMIC LUPUS ERYTHEMATOSUS
146
Choi May ANA-NEGATIVE SLE: RE-EVALUATION IN AN INTERNATIONAL INCEPTION COHORT
119
Davidson Anne THE ROLE OF TLR8 IN LUPUS NEPHRITIS 071
Deng Guo-min THE ROLE OF NEUTROPHILS IN ORGAN TISSUE DAMAGE IN SLE 072
Dewi Sumartini CORRELATION BETWEEN THE LEVELS OF BIOMARKERS P1NP, BAFF and sCD40L SERUM WITH SKIN FIBROSIS BASED ON MODIFIED RODNAN’S SKIN SCORE IN SYSTEMIC SCLEROSIS
089
Domínguez Amaia HEALTH-RELATED QUALITY OF LIFE (HRQOL), EMOTIONALITY THE DAY-TO-DAY PROBLEM SOLVING AND COPING IN LUPUS PATIENTS
090
Doria Andrea LUPUS LOW DISEASE ACTIVITY STATE: PREVALENCE AND EFFECT ON DAMAGE ACCRUAL IN A MONOCENTRIC COHORT OF 293 SLE PATIENTS
170
Edar Mary Flor Joy HIGHEST FREQUENCY OF CLINIC VISITS AND HOSPITALIZATIONS IN SLE AMONG RHEUMATIC DISEASES: 8 YEAR CENSUS OF A TERTIARY RHEUMATOLOGY CENTER
120
Edar Mary Flor Joy DISEASE ACTIVITY PATTERNS AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A 3-YEAR OBSERVATIONAL STUDY
148
Elkon Keith TLR8 ACTIVATION IN NEUTROPHILS IMPAIRS IMMUNE COMPLEX PHAGOCYTOSIS THROUGH FURIN-DEPENDENT SHEDDING OF FCGRIIA
073
Fikry Achmad ANTI - TNF ALFA INDUCED LUPUS : A CASE REPORT 091
Fujieda Yuichiro CLINICAL SIGNIFICANCE OF ANTI-DNA/NR2 ANTIBODIES IN DE NOVO NPSLE AND POST-STEROID NPSLE
021
G Arvind STUDY OF FAMILIAL AGGREGATION OF AUTOIMMUNE DISEASES IN ASIAN INDIAN LUPUS PATIENTS(PROBANDS)
121
Gatto Mariele PREDICTORS OF RENAL REMISSION, RENAL INSUFFICIENCY AND DAMAGE IN LUPUS NEPHRITIS
122
Gladman Dafna PREDICTORS OF GOOD LONG-TERM RENAL OUTCOMES 157
Golder Vera CONSTRUCT VALIDITY ASSESSMENT OF THE LUPUS LOW DISEASE ACTIVITY STATE (LLDAS) – A CASE BASED VALIDITY STUDY
149
Gómez-Puerta Jose A URINARY TWEAK LEVELS AS BIOMARKER OF LUPUS NEPHRITIS IN COLOMBIAN SLE PATIENTS
022
Gómez-Puerta Jose A PREVALENCE OF Anti-DFS70 ANTIBODIES IN A COLOMBIAN COHORT: A CASE-CONTROL STUDY
023
Gottschalk Timothy CD11b REGULATES INFLAMMATION, AUTOIMMUNITY AND ASSOCIATED PATHOLOGY IN A MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS
074
Gupta Aman PROFILE OF HENOCH SCHONLEIN PURPURA (HSP) NEPHRITIS: 23 YEARS EXPERIENCE AT A TERTIARY CARE CENTRE IN NORTH INDIA
092
Hall Sue UNDERSTANDING DISEASE BURDEN, SEVERITY AND PROGRESSION IN PATIENTS WITH CUTANEOUS LUPUS ERYTHEMATOSUS IN A REAL-WORLD SETTING
027
Hall Susan Audrey TEMPORAL RELATIONSHIP OF CUTANEOUS LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS: A LARGE, RETROSPECTIVE COHORT STUDY
123
Hamijoyo Laniyati COMPARISON QUALITY OF LIFE OF PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SYSTEMIC SCLEROSIS
150
Hanly John CEREBROVASCULAR EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL, INCEPTION COHORT STUDY
151
Hasni Sarfaraz IDENTIFICATION OF MicroRNA PREDICTIVE OF TREATMENT RESPONSE IN LUPUS NEPHRITIS
024
He Jing LOW-DOSE IL-2 CIRCUMVENTED mTOR SIGNALING IN T CELLS IN THE TREATMENT OF SLE
025
Hirahara Shinya USEFULNESS OF SOLUBLE PD-1 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
026
Hoi Alberta TEN YEARS OF THE MONASH LUPUS CLINIC AND ONWARDS – MODEL OF A MULTIDISCIPLINARY SPECIALIST CLINIC PROVIDING IMPROVED HEALTHCARE QUALITY AND OUTCOMES FOR SLE PATIENTS
152
Hoi Alberta THE HIGH DISEASE ACTIVITY STATE IS AN ADVERSE PROGNOSTIC INDICATOR IN SLE AND DEFINES A CLINICALLY DISTINCT POPULATION
154
Hosono Yuji SPLICING FACTOR PROLINE/GLUTAMINE-RICH (SFPQ) IS A NOVEL AUTOANTIGEN OF anti-MDA5 ANTIBODY-POSITIVE DERMATOMYOSITIS/CLINICALLY AMYOPATHIC DERMATOMYOSITIS
093
Huang Jing-Long THE CHANGE OF COMPLEMENT REGULATORY PROTEINS AND DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEROMATOSUS
028
Huang Xiangyang THE ROLE OF PI3k, mTOR IN THE EXPRESSION OF INTERFERON –ALPHA INDUCED PROTEIN IFIT4 IN LUPUS
029
Huang Xiangyang THE CLINICAL ANALYSIS OF THE CHARACTERISTICS OF LUPUS MESENTERIC VASCULITIS (LMV) COMPARED WITH LUPUS NEPHRITIS
030
Inanc Murat A SINGLE CENTER EXPERIENCE OF RITUXIMAB TREATMENT IN 79 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
086
Islam Md. Nazrul TUBERCULAR INFECTION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS-A REPORT FROM AN ENDEMIC COUNTRY
084
Iwata Shigeru THE EFFICACY OF ANTI-CD20 ANTIBODY RITUXIMAB FOR REFRACTORY PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
002
Jindal Ankur IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH LOCALIZED SCLERODERMA- REPORT OF 4 PEDIATRIC CASES.
094
Karp David LIKELIHOOD OF PATIENTS WITH INCOMPLETE LUPUS TO ENTER A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF HYDROXYCHLOROQUINE
004
Karp David SLE RISK HAPLOTYPES ARE ASSOCIATED WITH DEVELOPMENT OF SEROLOGIC AUTOIMMUNITY IN HEALTHY INDIVIDUALS
031
Kasitanon Nuntana INCIDENCE OF LUPUS NEPHRITIS FLARES AFTER COMPLETE RESPONSE TO INDUCTION AND RECEIVING 18 MONTHS OF MAINTENANCE PHASE IN CLINICAL PRACTICE
124
Khoshkhui Maryam EVALUATION OF ATOPY AND EOSINOPHILIA IN PATIENTS WITH PSORIASIS
005
Kim Ji-Min A CASE OF HEMOPHATOCYTIC SYNDROME DEVELOPED IN A KOREAN FEMALE PATIENT WITH DERMATOMYOSITIS
095
Kim Dam ANTIPHOSPHOLIPID ANTIBODY POSITIVITY AND RELATED CLINICAL CHARACTERISTICS IN KOREAN LUPUS PATIENTS
144
Koilubaeva Gulazyk OUTCOMES OF PREGNANCY OF KYRGYZ SLE PATIENTS 112
Kolarov Zlatimir DYSREGULATION OF miRNAs EXPRESSION LEVELS AND DISEASE ACTIVITY IN SLE PATIENTS
059
Komura Kazuhiro NAILFOLD VASCULAR FINDINGS OF ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 ANTIBODY-POSITIVE PATIENTS WITH DERMATOMYOSITIS
033
Kusumo Wibowo Suryo Anggoro PREGNANCY OUTCOME OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN CIPTO MANGUNKUSUMO NATIONAL REFERRAL HOSPITAL, JAKARTA, INDONESIA
113
Lanata Cristina IDENTIFYING EXPOSURES TO CHEMICALS IN PATIENTS WITH SLE - “ A NON-TARGETED EXPOSOME APROACH"
034
Lang Tali LINKING MACROPHAGE MIGRATION INHIBITORY FACTOR AND NLRP3 IN THE PATHOGENESIS OF IL-1 DEPENDENT INFLAMMATORY DISORDERS
075
Lee Shin-Seok RISK FACTORS FOR AND COMPONENTS OF METABOLIC SYNDROME: A STRUCTURAL EQUATION MODELING ANALYSIS OF THE QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
035
Lee Young H0 CIRCULATING PROLACTIN LEVEL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ITS CORRELATION WITH DISEASE ACTIVITY: A META-ANALYSIS
036
Lee Sang-Heon THE USE OF HAND PERFUSION SCINTIGRAPHY TO ASSESS RAYNAUD’S PHENOMENON ASSOCIATED WITH HAND-ARM VIBRATION SYNDROME
096
Li Ting INVESTIGATION OF DATA CAPTURE TECHNOLOGY ON CLINICAL PHENOTYPE DISTRIBUTION OF 4150 PATIENTS WITH SLE
037
Li Tzu-Hao USING DECISION TREE TO IDENTIFY THE ITP WITH HIGH PROBABILITY OF SLE DEVELOPMENT FROM A NATIONWIDE COHORT STUDY
125
Louthrenoo Worawit CLINICAL FEATURES, OUTCOMES AND RISK FACTORS FOR THE DEVELOPMENT OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN THAI PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
097
Louthrenoo Worawit PERFORMACE OF SPECIFIC (SLE-QOL) AND GENERIC (SF-36) HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS – A LONGITUDINAL STUDY
155
Luu Queenie PROMOTES [PATIENT AND PHYSICIAN REPORTED OUTCOMES – MEASURES OF THE TRUE EXPERIENCE IN SLE]
156
Mackay Fabienne DELETION OF THE BAFF RECEPTOR TACI FULLY PROTECTS AGAINST SLE WITHOUT REDUCTION OF B CELL NUMBERS AND FUNCTION.
076
Macri Christophe THE CONTRIBUTION OF INTERFERON LAMBDA TO SLE 077
Manjarrez Orduno
Nataly HIGH FREQUENCY OF CIRCULATING TERMINALLY DIFFERENTIATED CD8+ T CELLS CHARACTERIZE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH RENAL INVOLVEMENT
038
Marinho António EFFECT OF HIGH DOSE CHOLECALCIFEROL DURING SLE FLARES IN miR-146a EXPRESSION, REGULATORY T-CELLS AND IL-17A EXPRESSION.
039
Marinho António RELATION OF VITAMIN D LEVELS IN SLE NUMBER OF SEVERE FLARES
158
Masri Muchtar Raveinal POLYMORPHISM PROMOTOR GENE OF IL-4 AND IL-4 LEVEL AT GRAVES DISEASE PATIENTS
040
Meroni Marianna SAFETY AND EFFICACY OF MODIFIED-RELEASE PREDNISONE IN SYSTEMIC LUPUS ERYTHEMATOUS PREGNANCIES: AN IMPLEMENTED COHORT
114
Migliore Frank IMPROVING THE QUALITY OF CARE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) THROUGH TIME-STRUCTURED, INFORMATION TECHNOLOGY-ENHANCED, QUALITY IMPROVEMENT INDICATOR-DRIVEN PATIENT MANAGEMENT.
159
Mirfeizi Zahra CORRELATION BETWEEN SIX MINUTE WALK TEST AND PLASMA PROBNP LEVEL WITH ECHOCARDIOGRAPHIC FINDINGS OF PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS
041
Mohamed Said Mohd Shahrir CASE SERIES INVOLVING OBSTETRICS EXPERIENCES AND OUTCOMES IN CONNECTIVE TISSUE DISEASE PATIENT IN UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTRE (UKMMC): A SINGLE CENTRE EXPERIENCE
042
Mohamed Said Mohd Shahrir HYPERPROLACTINAEMIA ASSOCIATION WITH LUPUS NEPHRITIS DISEASE ACTIVITY
043
Mohammed Medhat Ali
Basma CLINICAL CHARACTERISTICS OF SYSTEMIC LUPUS ERYTHREMATOSUS IN AN EGYPTIAN POPULATION: A DESCRIPTIVE RETROSPECTIVE CASE SERIES
127
Mok Chi-Chiu EFFECT OF DISEASE REMISSION ON ORGAN DAMAGE AND QUALITY OF LIFE IN CHINESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
160
Mok Chi-Chiu SERUM 25-HYDROXYVITAMIN D3 LEVELS AND FLARES OF SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL COHORT ANALYSIS
161
Monaghan Katherine IDENTIFICATION OF PLASMACYTOID DENDRITIC CELL INDUCED PROTEINS AS POTENTIAL BIOMARKERS FOR JNJ-56022473
044
Moon Kiwon THE PREVALENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS HAS INCREASED IN SOUTH KOREA
128
Moriyama Rina CLINICAL USEFULNESS OF QUANTITATIVE MEASUREMENT OF ANTI-M-TYPE PHOSPHOLIPASE A2 RECEPTOR ANTIBODIES IN PATIENTS WITH MEMBRANOUS NEPHROPATHY AND COMPARISONS OF THREE QUANTITATIVE METHODS
032
Mukai Masaya PREGNANCY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN OUR HOSPITAL.
115
Nagaraju Shankar Prasad ANA NEGATIVE RENAL LIMITED LUPUS NEPHRITIS –A RARE ENTITY
098
Nesbit Stephanie PREDICTORS OF EARLY RESPONSE TO RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE BRITISH ISLES LUPUS ASSESSMENT GROUP BIOLOGICS REGISTER (BILAG-BR)
045
Nishiyama Susumu INCREASED CYSTATIN C/CREATININE RATIO REFLECTS HIGH DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
162
Nossent Johannes EVIDENCE FOR A PRO-INFLAMMATORY AS WELL AS PROTECTIVE ROLE FOR IL-17A IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
046
Nossent Johannes LUPUS NEPHRITIS IN INDIGENOUS AUSTRALIANS: INCIDENCE, HISTOLOGY AND OUTCOME.
129
Odhiambo Jackline AN EVALUATION OF QUALITY OF LIFE IN AMBULATORY PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ATTENDING RHEUMATOLOGY CLINIC IN KENYATTA NATIONAL HOSPITAL
163
Ogura Takehisa COMPARISON OF ULTRASONOGRAPHIC JOINT AND TENDON INVOLVEMENTS IN HANDS BETWEEN EARLY, TREATMENT-NAÏVE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
099
Olteanu Rodica CUTANEOUS LUPUS ERYTHEMATOSUS -EVALUATION OF LABORATORY INVESTIGATIONS COSTS FOR HOSPITALIZED CASES IN BUCHAREST DERMATOLOGICAL CLINIC COMPARED TO RECOMMENDED CORE SET INVESTIGATIONS BY EUROPEAN GUIDELINES
100
Ooi James DISCORDANCE OF PATIENT AND PHYSICIAN HEALTH STATUS CONCERNS IN SYSTEMIC LUPUS ERYTHEMATOSUS
164
Oon Shereen SERUM CYTOKINE ANALYSIS AND TRANSCRIPTIONAL BLOOD PROFILING REVEAL AN ASSOCIATION BETWEEN IL-3 AND IFN IN HUMAN SLE
047
Padiyar Shivraj URINARY VCAM 1 AS A DISEASE ACTIVITY INDICATOR IN LUPUS NEPHRITIS
048
Paras Bryan PREDICTORS OF END-STAGE RENAL DISEASE IN FILIPINOS WITH LUPUS NEPHRITIS: A CASE-CONTROL STUDY
130
Pawlak-Bus Katarzyna CLINICAL AND IMMUNOLOGICAL REMISSION IN POLISH COHORT OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
101
Pawlak-Bus Katarzyna CLINICAL AND IMMUNOLOGICAL ACTIVITY IN POLISH COHORT OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS TREATED WITH GLUCOCORTICOIDS
102
Perez-Alvarez Alberto THE ASSOCIATION BETWEEN WORLD DEVELOPMENT INDICATORS PER COUNTRY AND GENDER RATIO IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A BIG DATA APPROACH ANALYSIS
131
Perez-Alvarez Alberto BIG DATA IN SYSTEMIC LUPUS ERYTHEMATOSUS: PHENOTYPIC DISEASE EXPRESSION OF 171,000 ADULT PATIENTS
132
Perez-Alvarez Alberto WORLDWIDE PICTURE OF RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS USING A BIG DATA ANALYTICAL APPROACH
133
Petersen Martine Prütz FIRST REPORT OF INTRAUTERINE PERICARDIOCENTESIS IN A FETUS WITH NEONATAL LUPUS ERYTHEMATOSUS
116
Petri Michelle VITAMIN D DEFICIENCY IS ASSOCIATED WITH INCEASED SERUM CHOLESTEROL AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
165
Pettersson Susanne A COMPARISON OF PATIENTS’ AND PHYSICIANS’ ASSESSMENTS OF DISEASE ACTIVITY USING THE SWEDISH VERSION OF THE SYSTEMIC LUPUS ACTIVITY QUESTIONNAIRE
103
Pettersson Susanne COMPARISONS OF FATIGUE, ANXIETY AND DEPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS, SYSTEMIC SCLEROSIS AND ANTI-NEUTROPHIL CYTOPLASMATIC ANTIBODY-ASSOCIATED VASCULITIS
104
Peycheva Veneta LABORATORY FINDINGS OF SYNOVIAL FLUID IN CONNECTIVE TISSUE DISEASES
105
Pisitkun Prapaporn TMEM173/STING IS CRUCIAL FOR LUPUS DEVELOPMENT IN Fcgr2b-DEFICIENCY MICE
078
Potturi Pragna A COMPARISON OF OVARIAN RESERVE IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING TREATMENT WITH INTRAVENOUS CYCLOPHOSPHAMIDE V/S ORAL MYCOPHENOLATE MOFETIL
007
Prabir Das Prabir ASSOCIATION OF C4A AND C4B GENOMIC COPY NUMBER VARIATIONS IN ADULT AND PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS
049
Qian Jie THE PATHOGENIC MECHANISMS OF SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED GENES PNP, PLEKHF2 AND ANKRD44
051
Rahmawati Lita INTERLEUKIN-17 (IL-17) SERUM AND CORRELATION WITH DISEASE ACTIVITY IN NEPHRITIS AND NON LUPUS NEPHRITIS
166
Ramamoorthy Ramesh CORRELATION OF URINARY BIOMARKERS MCP1 AND NGAL WITH LUPUS NEPHRITIS(LN) HISTOLOGY AND DISEASE ACTIVITY SCORE
052
Ramsey-Goldman Rosalind ALGORITHMS TO IDENTIFY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) FROM ELECTRONIC HEALTH RECORD (EHR) DATA
167
Ranjana Walker Minz
Ranjana UNIQUE ASSOCIATION OF HLA-DRB1*15, HLA DRB1*03 AND EBV WITH ADULT AND PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN NORTH INDIA
050
Raymond Warren PRINCIPAL COMPONENT ANALYSIS AS A METHOD TO UNRAVEL THE RELATION BETWEEN DISEASE ACTIVITY AND CYTOKINE PROFILING IN SYSTEMIC LUPUS ERYTHEMATOSUS
134
Raymond Warren HOSPITALISATION FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN WESTERN AUSTRALIA DOUBLES THE ALL-CAUSE MORTALITY RISK COMPARED TO CONTROLS, ESPECIALLY FOR MEDICARE RELIANT AND MALE PATIENTS
135
Raymond Warren HOSPITALISATION FOR COMORBID CONDITIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IS MORE FREQUENTLY DUE TO CARDIOVASCULAR AND RENAL COMPLICATIONS, SUBSEQUENTLY INCREASING THE RISK OF DEATH
136
Reynolds Mathew ASSESSING THE QUALITY, RELIABILITY AND READABILITY OF ONLINE HEALTH INFORMATION REGARDING SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
137
Ruifang Wu STUDY ON THE ROLE AND MECHANISMS OF ABERRANT EXPRESSION OF TRANSCRIPTION FACTOR WT1 IN THE PSORIASIS VULGARIS LESION FORMATION
053
Santos Vivian FAMILIALITY AND CONCORDANCE OF PRESENTING MANIFESTATIONS AMONG FILIPINO PATIENTS FROM LUPUS MULTIPLEX FAMILIES
054
Scofield Hal VERY RARE X CHROMOSOME ANEUPLOIDIES IN LUPUS AND SJOGREN'S
055
Seger Schristina GOING DOWN A DIFFERENT PATH”: A QUALITATIVE EXPLORATION OF COSTS INCURRED BY CANADIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
147
Selvaraja Malarvili ROLE OF CYTOKINE IL-5 AND IL-25 AS BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS
056
Senturk Taskin THE RELATIONSHIP BETWEEN IL-10, IL-17, IL-23 AND VITAMIN D LEVELS, AND DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS
057
Senturk Taskin SULFASALAZINE-RELATED HYPERSENSITIVITY REACTIONS IN PATIENTS WITH RHEUMATIC DISEASES
171
Setiabudiawan Budi INDONESIAN EPIDEMIOLOGIC DATA OF PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS
139
Shimizu Takashi THE LEVEL OF CD64 EXPRESSION ON MONOCYTE CORRELATES WITH THE ACTIVITY OF LUPUS NEPHRITIS
058
Smith Kevin ANA AND ENA TESTING ALGORITHM: PERSPECTIVE OF A LARGE PUBLIC HOSPITAL LABORATORY IN NEW ZEALAND
106
Soh May Ching COULD PRETERM DELIVERY BE A SURROGATE MARKER FOR ACCELERATED DEVELOPMENT OF CARDIOVASCULAR EVENTS IN WOMEN WITH SLE?
140
Tan Justina Wei Lynn RAPIDLY PROGRESSIVE ILD IN IIM – THE SINGAPOREAN EXPERIENCE
060
Tan Ying PLASMA ADAMTS-13 ACTIVITY IN PROLIFERATIVE LUPUS NEPHRITIS: A LARGE COHORT STUDY FROM CHINA
107
Tan Cheryl Anne MATERNAL AND FETAL OUTCOMES AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A SINGLE CENTER STUDY
117
Tanaka Yoshiya DISEASE SEVERITY AND BURDEN IN JAPANESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM CLAIMS DATABASE
126
Tangtanatakul Pattarin DOWN-REGULATION OF miR-10a INDUCES IL-8 IN HUMAN MESANGIAL CELLS STIMULATED WITH Anti-dsDNA IgG ANTIBODIES
061
Teh Lee-Suan USE OF A PATIENT-REPORTED OUTCOME MEASURE, THE LUPUSQOL TO REFER PATIENTS FOR FURTHER SUPPORT – A PRELIMINARY STUDY
153
Teh Lee-Suan FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS 168
Thanadetsuntorn Chokchai COMPARISON OF CIRCULATING IMMUNE COMPLEX AND INTERLEUKIN-6 WITH STANDARD BIOMARKERS TO DETERMINE SLE DISEASE ACTIVITY
062
Tunnicliffe David INDUCTION AND MAINTENANCE TREATMENT OF PROLIFERATIVE LUPUS NEPHRITIS: AN UPDATED COCHRANE REVIEW.
008
Tunnicliffe David MULTI-SPECIALISTS’ PERSPECTIVES ON CLINICAL DECISION MAKING IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN INTERVIEW STUDY
108
Ugarte-Gil Manuel PREDICTORS OF REMISSION AND LOW LUPUS DISEASE ACTIVITY STATUS (LLDAS): DATA FROM A MULTI-ETHNIC, MULTINATIONAL LATIN AMERICAN LUPUS COHORT
009
Undurti Das IS LUPUS AN INFLAMMATION RESOLUTION DEFICIENCY DISORDER?
063
Undurti Das ROLE OF BIOACTIVE LIPIDS IN AUTOIMMUNE DISEASES INCLUDING LUPUS
064
Vanya Magdi ASSESSING THE CONTENT VALIDITY OF THE SF-36, THE SKINDEX-29+3 PATIENT REPORTED OUTCOMES (PRO) INSTRUMENTS, AND PAIN, FATIGUE IN PATIENTS WITH CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
169
Venegas Elaine RENAL ACTIVITY AND DAMAGE INCUR HIGHEST MEDICAL COSTS AMONG FILIPINO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
141
Wahono Cesarius Singgih THE EFFECT OF ADDING CURCUMIN ON VITAMIN D3 SUPPLEMENTATION ON THE DISEASE ACTIVITIES AND FATIQUE DEGREE, IN SLE PATIENTS WITH HYPOVITAMIN D
010
Wahono Cesarius Singgih THE EFFECT OF ADDING CURCUMIN ON VITAMIN D3 SUPPLEMENTATION ON ANTI-DSDNA LEVELS AND PROTEINURIA, IN SLE PATIENTS WITH HYPOVITAMIN D
011
Wahono Cesarius Singgih THE EFFECT OF ADDING CURCUMIN ON VITAMIN D3 SUPPLEMENTATION ON CYTOKINES BALANCE, IN SLE PATIENTS WITH HYPOVITAMIN D
012
Wahono Cesarius Singgih THE EFFECT OF VITAMIN D3 SUPPLEMENTATION ON THE ANTI-dsDNA LEVELS AND URINE PROTEIN IN SLE PATIENTS WITH HYPOVITAMIN D
013
Wahono Cesarius Singgih THE EFFECT OF VITAMIN D3 SUPPLEMENTATION ON THE DISEASE ACTIVITIES AND DEGREE OF FATIQUE IN SLE PATIENTS WITH HYPOVITAMIN D
014
Wang Guosheng IDENTIFICATION OF MAJOR CLINICAL CHARACTERISTICS OF CHINESE SLE PATIENTS AND LINEAR CORRELATIONS AMONG SLEDAI, SF-36 AND HADS-ANXIETY USING MOBLIE SMART SYSTEM OF DISEASE MANAGEMENT (SSDM)
003
Wang Jiehua ELEVATED IFIT3 IN MONOCYTES CONTRIBUTED TO HYPERACTIVE CGAS-STING SIGNALING PATHWAY IN SLE
065
Wang Jing Jing MASS SPECTROMETRIC SEQUENCING OF PRECIPITATING ANTI-RO REVEALS UNIQUE VH/VL PEPTIDE BIOMARKERS
066
Wang Ting TOLL-LIKE RECEPTOR 7 SIGNALING DRIVES TRANSITIONAL B CELLS EXPANSION AND AUTOANTIBODY PRODUCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS
079
Widhani Alvina SEVERE PERIPHERAL ARTERY DISEASE IN PATIENT WITH SCLERODERMA MANAGED WITH ENDOVASCULAR TREATMENT: A CASE REPORT
109
Xiao Fei THE LONG-TERM OUTCOMES ON LEFLUNOMIDE TREATMENT IN PATIENTS WITH LUPUS NEPHRITIS: A TWELVE-YEAR FOLLOW-UP STUDY
006
xu liling A CROSS-SECTIONAL STUDY ON APPLICATION OF GLUCOCORTICOID IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS IN CHINA
110
Yan Wang IN VIVO THERAPEUTIC SUCCESS OF MicroRNA-155 (miR-155) ANTAGOMIR IN A MOUSE MODEL OF LUPUS ALVEOLAR HEMORRHAGE
067
Yap Desmond Yat-Hin RELAPSE OF LUPUS NEPHRITIS – RISK FACTORS AND IMPACT OF MYCOPHENOLATE TREATMENT
142
Yap Desmond Yat-Hin PRE-EMPTIVE TREATMENT FOR ASYMPTOMATIC SEROLOGICAL REACTIVATION IN LUPUS NEPHRITIS PATIENTS – IMPACT ON CLINICAL FLARE RATE AND RENAL FUNCTION
143
Yeh Kuo-Wei SERUM IL-18 AS BIOMARKER IN PREDICTING LONG-TERM RENAL OUTCOME AMONG PEDIATRIC-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
068
Yim Ada Lok Yan AUTOIMMUNE-ASSOCIATED GENE CLEC16A REGULATES NLRP3 BUT NOT AIM2 INFLAMMASOME PATHWAY IN HUMAN MACROPHAGES
080
Yu Xiang MicroRNA-21 IS A CRITICAL REGULATOR OF AUTOIMMUNITY THROUGH PROMOTING EFFECTOR AND METABOLIC FUNCTION OF PATHOGENIC TH17 CELLS
069
Zamora Leonid RISK FACTORS FOR HERPES ZOSTER INFECTION AMONG FILIPINOS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE CONTROL STUDY
145
Zamora-Medina Maricarmen ANTI-RNP/Sm ANTIBODIES PLUS LUPUS ANTICOAGULANT AS RISK FACTOR FOR THROMBOSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
138
Zapata Carlos Andres CHARACTERIZATION OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO WERE ADMITTED TO A UNIVERSITY HOSPITAL IN BOGOTA-COLOMBIA BETWEEN 2008 AND 2016
111
Zhang Ruijun INCREASED PERIPHERAL CD8 T CELL RESPONSES IN SLE BY LOW-DOSE IL-2 TREATMENT
085
Zhao Ming DEFECT OF BDH2 CONTRIBUTES TO DNA HYPOMETHYLATION IN CD4+ T CELLS OF SYSTEMIC LUPUS ERYTHEMATOSUS
070